Local pharmaceutical companies surpassed multinational giants in research and development spending in investment-to-sales ratio last year, but still fell far behind when it came to the total amount.
According to an analysis by CEO Score Daily, an online-based local economic news outlet, Korean pharmaceutical firms invested 13 percent of their sales into R&D.